Current Research in Multiple Sclerosis
Latest Posts
Our Research Focus
Who We Are
Dr. Simon Zhornitsky is an expert in neurology research, including multiple sclerosis (MS) and Alzheimer's disease. He has authored over 80 peer-reviewed articles and has proposed numerous treatments for MS, which may help to promote remyelination and slow disease progression. Dr. Zhornitsky has conducted psychiatry and neurology research at the University of Montreal, University of Calgary, and Yale University School of Medicine. Currently, he works as a professor in the Department of Psychology at Southern Connecticut State University (SCSU).
Exploring New Findings
Prolactin in Multiple Sclerosis
Prolactin, a hormone primarily associated with lactation and reproductive functions, has garnered attention in recent years for its potential involvement in multiple sclerosis. Prolactin has important effects on the immune system and myelin repair, which may contribute to the pathophysiology of MS, an autoimmune disease that affects the central nervous system.
Protective Effect of Vitamin D in Multiple Sclerosis
Vitamin D has become a key focus in the study of multiple sclerosis, with increasing evidence suggesting that it plays a significant role in both the risk and progression of the disease. One environmental factor that has garnered attention is vitamin D, a fat-soluble vitamin with well-established roles in bone health and immune system regulation.
Remyelinating Treatment for Multiple Sclerosis
Quetiapine, an atypical antipsychotic medication primarily used to treat schizophrenia, bipolar disorder, and major depressive disorder, has recently attracted interest in the context of multiple sclerosis (MS) for its potential remyelinating properties. Quetiapine may have a role in promoting myelin repair, an essential process for MS patients who experience demyelination in the central nervous system.
Read News About Our Research
Gaining crucial insights from our research efforts allows us to offer valuable perspectives, guidance, and resources to individuals navigating the complexities of multiple sclerosis, fostering resilience and knowledge.
Multiple Sclerosis and Cholesterol
Cholesterol has been a topic of increasing interest in the study of multiple sclerosis, a chronic autoimmune disease that affects the central nervous system. While the exact role of cholesterol in MS remains complex, research suggests it plays both protective and potentially harmful roles in the disease's progression.
A Biography of Dr. Simon Zhornitsky
Dr. Simon Zhornitsky is a world-class researcher in multiple sclerosis, with a focus on remyelinating therapies. He has received multiple awards from the MS Society of Canada.